Clinical Trial Update: Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment [NA]

View source ↗

Summary

A completed longitudinal fMRI study investigating neuroimaging biomarkers in anxiety disorder and obsessive-compulsive disorder with Paroxetine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Obsessive-compulsive Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Central South University | Conditions: Anxiety Disorder, Obsessive-Compulsive Disorder | NA | Status: COMPLETED